By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves New Blood Test for Prostate Cancer For Men With PSA Levels Just Above Normal Range
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Diagnostics > FDA Approves New Blood Test for Prostate Cancer For Men With PSA Levels Just Above Normal Range
Diagnostics

FDA Approves New Blood Test for Prostate Cancer For Men With PSA Levels Just Above Normal Range

BarbaraDuck
BarbaraDuck
Share
2 Min Read
SHARE

Perhaps this will add some additional definitive information on the PSA testing which has been in the news frequently for discussion as to imagewhether it should be used for screening or not.  This test appears to add some additional decision making information if any ac

Perhaps this will add some additional definitive information on the PSA testing which has been in the news frequently for discussion as to imagewhether it should be used for screening or not.  This test appears to add some additional decision making information if any actions or treatments are needed/discussed.  Last year at UCLA a new PSA testing format was developed called the A+PSA test so perhaps with both tests more decision making information can be obtained with fewer false positives.  BD




A+PSA New Test For Prostate Cancer Is More Specific and Reduces False-Positives-Study at UCLA

 


A blood test for prostate cancer billed by its manufacturer as “an answer to the current PSA [prostate-specific antigen] testing controversy” has won FDA approval, the company said.

Beckman Coulter said Monday that the agency had okayed its premarket approval application for the so-called Prostate Health Index test, which incorporates measurement of a PSA precursor protein called [-2] pro-PSA along with total and free PSA.

According to the co-discoverer of [-2] pro-PSA, Kevin Slawin, MD, of Memorial Hermann-Texas Medical Center in Houston, the marker is more closely associated with prostate cancer than total and free PSA. Combining the three markers makes the Prostate Health Index more specific than conventional PSA testing.

http://www.medpagetoday.com/HematologyOncology/ProstateCancer/33486

More Read

fitness tracker
How the US Healthcare Industry Can Encourage Fitness Tracking
New Concussion Sensors, Apps Help Without Solving Key Diagnostic Issues
Customer Service Portal for Medical Equipment Saves Time and Work
Diagnostic Reading #44: Five Must-Read Articles From the Past Week
Will Shear Wave Elastography Make an Impact in Liver Disease?


  

TAGGED:prostate cancerscreening
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Clinical Collaboration: The Evolution of the VNA

December 13, 2014
DiagnosticsTechnology

How Rapid Blood Testing Solves Blood Lab Wait Time Issues

January 12, 2021

Parkinson’s Disease: 14 Early Warning Signs of Onset

June 4, 2013
BioPharma Beat logo
DiagnosticseHealthHome HealthMedical DevicesMedical InnovationsMedical RecordsMobile HealthNewsPolicy & LawPublic HealthRemote DiagnosticsTechnologyWellness

BioPharma Beat: mHealth Apps – to Regulate or Not to Regulate

May 12, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?